[
  {
    "ts": null,
    "headline": "Gilead Sciences: Margin Expansion And Cash Flow Strength Underpriced",
    "summary": "Gilead Sciences is undervalued, with a Buy rating and a DCF-based target price of $141, implying 13.4% upside. Click here to know more.",
    "url": "https://finnhub.io/api/news?id=06c163e8bd0315512ecb42257c7017ab63fc8ead1dea2874327976662fb7c5d0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768914216,
      "headline": "Gilead Sciences: Margin Expansion And Cash Flow Strength Underpriced",
      "id": 138188738,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1081504232/image_1081504232.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences is undervalued, with a Buy rating and a DCF-based target price of $141, implying 13.4% upside. Click here to know more.",
      "url": "https://finnhub.io/api/news?id=06c163e8bd0315512ecb42257c7017ab63fc8ead1dea2874327976662fb7c5d0"
    }
  }
]